Fusarin C acts like an estrogenic agonist and stimulates breast cancer cells in vitro

T. E. Sondergaard*, F. T. Hansen, S. Purup, A. K. Nielsen, E. C. Bonefeld-Jørgensen, H. Giese, J. L. Sørensen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

48 Citations (Scopus)

Abstract

Fusarin C is a mycotoxin produced by several Fusarium species and has been associated with esophageal cancer due to its carcinogenic effects. Here, we report that fusarin C stimulates growth of the breast cancer cell line MCF-7. This suggests that fusarin C can act as an estrogenic agonist and should be classified as a mycoestrogen. MCF-7 cells were stimulated in the range between 0.1 and 20. μM and inhibited when the concentration exceeded 50. μM. The toxicity of fusarin C is comparable to other mycoestrogens such as zearalenone, but the chemical structure of fusarin C is very different from other known estrogen agonists. Furthermore, the toxicity of fusarin C was tested in five additional human cell lines Caco 2, U266, PC3, MDA-MB-231 and MCF-10a which were all inhibited when the concentration of fusarin C exceeded 10. μM. To the best of our knowledge this is the first report on the mycoestrogenic properties of fusarin C.

Original languageEnglish
JournalToxicology Letters
Volume205
Issue number2
Pages (from-to)116-121
Number of pages6
ISSN0378-4274
DOIs
Publication statusPublished - 28 Aug 2011
Externally publishedYes

Keywords

  • Breast cancer
  • Estrogen
  • Estrogen receptor
  • Fusarin C
  • Fusarium
  • MCF-7 cells

Fingerprint

Dive into the research topics of 'Fusarin C acts like an estrogenic agonist and stimulates breast cancer cells in vitro'. Together they form a unique fingerprint.

Cite this